Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 6/20 | 0.57 |
| ▸ | KIF11 | P52732 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | CYP3A5 | P20815 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7068828 | 1.00 | CYP19A1 (0.57) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| SCHEMBL29387897 | 1.00 | CYP19A1 (0.57) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| Lithium SCHEMBL30216964 | 0.98 | CYP19A1 (0.55) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| Water SCHEMBL27638122 | 0.98 | CYP3A4 (0.56) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| Hydrochloric Acid SCHEMBL21796041 | 0.98 | CYP19A1 (0.55) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| Ammonia Solution, Strong SCHEMBL28655959 | 0.98 | CYP19A1 (0.55) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| Benzene SCHEMBL29164330 | 0.98 | CYP19A1 (0.55) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| Bromide SCHEMBL29204966 | 0.98 | CYP19A1 (0.55) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| Lithium Ion SCHEMBL28974295 | 0.95 | CYP19A1 (0.53) | CYP19A1KIF11CYP3A4CYP3A5NPC1 | |
| Hydrazine SCHEMBL28287990 | 0.95 | CYP19A1 (0.53) | CYP19A1KIF11CYP3A4CYP3A5NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | NOVARTIS PHARMA AG (CH) | 2025-12-23 | — | — | US | claimed |
| EP-4644385-A1 | TIPARP INHIBITOR COMPOUNDS | AbbVie Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| WO-2025122636-A1 | METHOD FOR THE SYNTHESIS OF ACRYLATE DERIVATIVES | Orthobond Corporation (US) | 2025-06-12 | — | — | WO | claimed |
| CN-119798147-A | Preparation method of 3-trifluoromethyl pyridine | 陕西中蓝化工科技新材料有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119591507-A | Gem-difluorocyclopentane compounds and methods of synthesizing the same | 南通大学 | 2025-03-11 | — | — | CN | claimed |
| CN-118973277-A | Tin-containing perovskite solar cell doped with 3-trifluoromethyl pyridine and preparation method thereof | 嘉兴大学 | 2024-11-15 | — | — | CN | claimed |
| US-20240270748-A1 | TRICYCLIC HETEROCYCLES | MERCK PATENT GMBH (DE) | 2024-08-15 | — | — | US | claimed |
| CN-118271259-A | Organic single-molecule white light material based on 1,3, 5-triphenoxazine/thia/selenazine arene olefination | 重庆大学 | 2024-07-02 | — | — | CN | claimed |
| EP-4105202-B1 | METHOD FOR PREPARING 2-CHLORO-5-TRIFLUOROMETHYLPYRIDINE | ZHEJIANG LANTIAN ENVIRONMENTAL PROT HI TECH CO LTD (CN) | 2024-05-01 | — | — | EP | claimed |
| CN-114456134-B | Alpha-fluoroalkyl substituted cyclopropyl alcohol compound, and preparation method and application thereof | 武汉大学 | 2024-04-26 | — | — | CN | claimed |
| EP-0074192-A2 | Chloro-trifluoromethyl pyridines | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-03-16 | — | — | EP | claimed |
| EP-0014033-B1 | HALOGENATION OF PYRIDINE COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-02-16 | — | — | EP | claimed |
| EP-0065358-A1 | Production of 3-trichloromethyl- and 3-trifluoromethyl-pyridines | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-11-24 | — | — | EP | claimed |
| US-4288599-A | VAPOR PHASE HALOGENATION OF B-PICOLINE WITH CHLORINE AND HYDROGEN FLUORIDE | ISHIHARA SANGYO KAISHA LTD. (JP) | 1981-09-08 | — | — | US | claimed |
| US-4288600-A | VAPOR PHASE CHLORINATION | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-09-08 | — | — | US | claimed |
| US-4284783-A | Liquid phase preparation of 2-chloro-5-trifluoromethylpyridine and 2-chloro-5-perchlorofluoromethylpyridine | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-08-18 | — | — | US | claimed |
| US-4259496-A | Halogenation of pyridine compounds | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-03-31 | — | — | US | claimed |
| US-4257857-A | Liquid phase preparation of 2-chloro-5-trifluoromethylpyridine and 2-chloro-5-perchlorofluoromethylpyridine | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-03-24 | — | — | US | claimed |
| EP-0014033-A2 | Halogenation of pyridine compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1980-08-06 | — | — | EP | claimed |
| EP-0013474-A2 | Preparation of 2-chloro-5-trifluoromethylpyridine | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1980-07-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240270748-A1 | TRICYCLIC HETEROCYCLES | YAP1, TERF2IP, TEAD1 | CYP19A1 3057/4885KIF11 3116/4885CYP3A4 3835/4885 |
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | STING1, CGAS, IRF3 | CYP19A1 3649/4885KIF11 4125/4885CYP3A4 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.